What is the Natco Pharma Ltd share price today?

The share price of NSE:NATCOPHARM-EQ on 01 Oct 2026 (as of 15:04:21 IST) is ₹820.8.

What is the NSE:NATCOPHARM-EQ 52 week high low price?

Over the past 52 weeks (as of 01 Oct 2026), the NSE:NATCOPHARM-EQ 52 week high low range shows a high of ₹1226.8 and a low of ₹792.05.

What is the Natco Pharma Ltd market cap?

As on 01 Oct 2026, Natco Pharma Ltd market cap is ₹148088000000.

What is the shareholding pattern of Natco Pharma Ltd Stock?

The shareholding pattern of Natco Pharma Ltd, as of last reported-on 30 Jun 2026 is: Promoters: 49.42% Foreign Institutional Investors (FII): 16.99% Domestic Institutional Investors (DII): 3.7% Mutual Funds: 1.92% Retail & Others: 27.97% This demonstrates an outstanding distribution of ownership.

What are the PE and PB ratios of Natco Pharma Ltd?

The Price-to-Earnings (PE) ratio of Natco Pharma Ltd is 12.9414, and the Price-to-Book (PB) ratio is 1.8927, as on 01 Oct 2026.

Natco Pharma Share Price

781.60+0.00 (-0.53%)

-5.23% past 1 Year

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

1 Day

-0.53%

1 Week

-0.10%

1 Month

-4.86%

3 Month

-13.64%

6 Month

-32.92%

YTD

-12.74%

1 Year

-5.23%

5 Year

-8.33%

10 Year

+36.54%

Max

+15351.33%

YTD

10Y

MAX

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Price Analysis

1 Day

1 Week

1 Month

3 Months

6 Months

1 Year

Low

779.20

773.60

High

794.90

827.00

956.99

1216.81

About

Natco Pharma is engaged in the business of pharmaceuticals and agricultural chemicals which comprises research and development, manufacturing and selling of bulk drugs, finished dosage formulations. The Company has manufacturing Read more

Pharmaceuticals & Drugs

Smallcap

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats

1. Premium insight available after login

2. Sign in to view full SWOT analysis

3. Unlock strengths, weaknesses, opportunities & threats

QVT

Quality

0/100-

Valuation

0/100-

Technical

0/100-

Peer Stocks

1 week

1 month

1 year

Name

SUNPHARMANSE

DIVISLABNSE

TORNTPHARMNSE

LAURUSLABSNSE

ZYDUSLIFENSE

DRREDDYNSE

CIPLANSE

MANKINDNSE

AUROPHARMANSE

LUPINNSE

NATCOPHARMNSE

LTP

1W Low

1W High

Market cap (₹)

1769.9-7.8 (-0.44%)

1722

1855

4,24,202Cr

10064+284 (2.90%)

9621.50

10064

2,64,141Cr

4650+36.6 (0.79%)

4532

4675

1,74,402Cr

2323-82.5 (-3.43%)

2206.10

2441.90

1,26,811Cr

1240.6-4.9 (-0.39%)

1182

1254.20

1,23,685Cr

1368.3+16.3 (1.21%)

1336.70

1368.30

1,11,868Cr

1396.9+18 (1.31%)

1357

1396.90

1,11,650Cr

2475-17.8 (-0.71%)

2457.90

2528

1,02,196Cr

1694.5+13.1 (0.78%)

1647.20

1697.40

96,951Cr

2015.9+4.9 (0.24%)

1974

2033.80

91,301Cr

781.6-0.8 (-0.10%)

779.20

800.90

15,420Cr

Natco Pharma Share Price

781.60+0.00 (-0.53%)

-5.23% past 1 Year

Financial overview

Compounded Sales Growth

10 years15%

5 years15%

3 years15%

Last year-8%

Compounded Profit Growth

10 years25%

5 years26%

3 years26%

Last year-27%

Stock Price CAGR

10 years3%

5 years-2%

3 years2%

1 year-5%

Return on Equity

10 years20%

5 years18%

3 years23%

Last year16%

CAGR%

Sales

Profits

Returns

ROE

10Y	5Y	3Y	TTM
15%	15%	15%	-8%
25%	26%	26%	-27%
3%	-2%	2%	-5%
20%	18%	23%	16%

Peer Comparison

Symbol

SUNPHARMA

DIVISLAB

TORNTPHARM

LAURUSLABS

ZYDUSLIFE

DRREDDY

CIPLA

MANKIND

AUROPHARMA

LUPIN

NATCOPHARM

Price	M.Cap (₹)	PE Ratio	EPS (₹)	EV/EBITDA	Annual PAT
1,769.9	₹424202 Cr	38.68	8.29	58.23	₹11479 Cr
10,064	₹264141 Cr	90.3	34.04	128.41	₹2568 Cr
4,650	₹174402 Cr	82.11	14.04	106.21	₹2163 Cr
2,323	₹126811 Cr	94.64	8.17	33.94	₹889 Cr
1,240.6	₹123685 Cr	27.41	9.42	62.53	₹5040 Cr
1,368.3	₹111868 Cr	39.95	11.08	59.2	₹4196 Cr
1,396.9	₹111650 Cr	38.54	10.86	52.6	₹3879 Cr
2,475	₹102196 Cr	45.57	17.23	76.26	₹1913 Cr
1,694.5	₹96951 Cr	26.11	17.95	96.84	₹3505 Cr
2,015.9	₹91301 Cr	16.51	30.95	154.35	₹5333 Cr
781.6	₹15420 Cr	13.48	11.44	68.33	₹1419 Cr

Profit & Loss

Consolidated

Standalone

Quarterly

Yearly

₹

Name

Net Revenue

Other Income

Total Revenue

Total Expenditure

Operating Profit

Interest Expense

PBT

Net Profit

Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021	Mar 2021	Dec 2020	Sep 2020	Jun 2020	Mar 2020	Dec 2019	Sep 2019	Jun 2019	Mar 2019	Dec 2018	Sep 2018	Jun 2018	Mar 2018	Dec 2017	Sep 2017	Jun 2017	Mar 2017	Dec 2016	Sep 2016	Jun 2016	Mar 2016	Dec 2015	Sep 2015	Jun 2015	Mar 2015	Dec 2014	Sep 2014	Jun 2014	Mar 2014	Dec 2013	Sep 2013	Jun 2013	Mar 2013	Dec 2012	Sep 2012	Jun 2012	Mar 2012	Dec 2011	Sep 2011	Jun 2011	Mar 2011	Dec 2010	Sep 2010	Jun 2010	Mar 2010	Dec 2009	Sep 2009	Jun 2009	Mar 2009	Dec 2008	Sep 2008	Jun 2008	Mar 2008	Dec 2007	Sep 2007	Jun 2007	Dec 2006	Sep 2006	Jun 2006	Mar 2006
₹735 Cr	₹739 Cr	₹647 Cr	₹1363 Cr	₹1329 Cr	₹1221 Cr	₹475 Cr	₹1371 Cr	₹1363 Cr	₹1068 Cr	₹759 Cr	₹1031 Cr	₹1141 Cr	₹898 Cr	₹493 Cr	₹432 Cr	₹885 Cr	₹597 Cr	₹561 Cr	₹377 Cr	₹410 Cr	₹331 Cr	₹355 Cr	₹802 Cr	₹563 Cr	₹455 Cr	₹482 Cr	₹486 Cr	₹492 Cr	₹456 Cr	₹557 Cr	₹544 Cr	₹539 Cr	₹768 Cr	₹562 Cr	₹427 Cr	₹445 Cr	₹578 Cr	₹679 Cr	₹468 Cr	₹340 Cr	₹407 Cr	₹276 Cr	₹243 Cr	₹224 Cr	₹201 Cr	₹195 Cr	₹219 Cr	₹210 Cr	₹184 Cr	₹203 Cr	₹179 Cr	₹173 Cr	₹168 Cr	₹178 Cr	₹180 Cr	₹115 Cr	₹154 Cr	₹145 Cr	₹127 Cr	₹123 Cr	₹115 Cr	₹118 Cr	₹127 Cr	₹116 Cr	₹118 Cr	₹117 Cr	₹118 Cr	₹109 Cr	₹127 Cr	₹110 Cr	₹107 Cr	₹94 Cr	₹91 Cr	₹90 Cr	₹85 Cr	₹67 Cr	₹62 Cr	₹59 Cr	₹60 Cr	₹50 Cr
₹59 Cr	₹78 Cr	₹58 Cr	₹100 Cr	₹62 Cr	₹66 Cr	₹176 Cr	₹64 Cr	₹48 Cr	₹42 Cr	₹37 Cr	₹29 Cr	₹20 Cr	₹29 Cr	₹21 Cr	₹21 Cr	₹34 Cr	₹14 Cr	₹30 Cr	₹38 Cr	₹17 Cr	₹28 Cr	₹31 Cr	₹26 Cr	₹19 Cr	₹22 Cr	₹31 Cr	₹33 Cr	₹21 Cr	₹31 Cr	₹23 Cr	₹40 Cr	₹36 Cr	₹20 Cr	₹11 Cr	₹6 Cr	₹3 Cr	-₹60 L	₹6 Cr	₹3 Cr	₹5 Cr	₹2 Cr	₹5 Cr	₹2 Cr	₹2 Cr	₹3 Cr	₹7 Cr	₹3 Cr	₹2 Cr	₹10 Cr	₹1 Cr	₹2 Cr	₹4 Cr	₹2 Cr	₹6 Cr	₹88 L	₹2 Cr	₹74 L	₹35 L	₹1 Cr	₹1 Cr	₹45 L	₹26 L	₹31 L	₹6 Cr	₹11 Cr	₹29 L	₹95 L	₹5 Cr	₹8 Cr	₹7 Cr	₹7 Cr	₹6 Cr	₹10 Cr	₹6 Cr	₹6 Cr	₹4 Cr	₹7 Cr	₹8 Cr	₹5 Cr	₹7 Cr
₹794 Cr	₹817 Cr	₹705 Cr	₹1463 Cr	₹1391 Cr	₹1287 Cr	₹651 Cr	₹1435 Cr	₹1411 Cr	₹1110 Cr	₹796 Cr	₹1061 Cr	₹1160 Cr	₹927 Cr	₹513 Cr	₹453 Cr	₹919 Cr	₹611 Cr	₹591 Cr	₹415 Cr	₹427 Cr	₹360 Cr	₹386 Cr	₹828 Cr	₹582 Cr	₹477 Cr	₹513 Cr	₹519 Cr	₹513 Cr	₹487 Cr	₹580 Cr	₹584 Cr	₹575 Cr	₹788 Cr	₹574 Cr	₹432 Cr	₹449 Cr	₹577 Cr	₹685 Cr	₹471 Cr	₹346 Cr	₹408 Cr	₹281 Cr	₹245 Cr	₹226 Cr	₹204 Cr	₹203 Cr	₹222 Cr	₹211 Cr	₹194 Cr	₹205 Cr	₹181 Cr	₹176 Cr	₹170 Cr	₹184 Cr	₹181 Cr	₹117 Cr	₹155 Cr	₹146 Cr	₹128 Cr	₹124 Cr	₹116 Cr	₹119 Cr	₹128 Cr	₹122 Cr	₹128 Cr	₹117 Cr	₹119 Cr	₹113 Cr	₹135 Cr	₹117 Cr	₹114 Cr	₹100 Cr	₹101 Cr	₹95 Cr	₹90 Cr	₹71 Cr	₹69 Cr	₹67 Cr	₹65 Cr	₹57 Cr
₹596 Cr	₹662 Cr	₹535 Cr	₹836 Cr	₹816 Cr	₹771 Cr	₹483 Cr	₹613 Cr	₹602 Cr	₹627 Cr	₹535 Cr	₹617 Cr	₹656 Cr	₹600 Cr	₹428 Cr	₹379 Cr	₹529 Cr	₹654 Cr	₹495 Cr	₹341 Cr	₹334 Cr	₹286 Cr	₹303 Cr	₹555 Cr	₹420 Cr	₹357 Cr	₹379 Cr	₹373 Cr	₹323 Cr	₹329 Cr	₹369 Cr	₹343 Cr	₹339 Cr	₹403 Cr	₹293 Cr	₹321 Cr	₹324 Cr	₹350 Cr	₹433 Cr	₹377 Cr	₹276 Cr	₹327 Cr	₹228 Cr	₹197 Cr	₹179 Cr	₹164 Cr	₹160 Cr	₹172 Cr	₹164 Cr	₹155 Cr	₹157 Cr	₹143 Cr	₹135 Cr	₹140 Cr	₹139 Cr	₹142 Cr	₹89 Cr	₹130 Cr	₹118 Cr	₹100 Cr	₹101 Cr	₹97 Cr	₹97 Cr	₹104 Cr	₹105 Cr	₹107 Cr	₹97 Cr	₹98 Cr	₹98 Cr	₹114 Cr	₹98 Cr	₹96 Cr	₹84 Cr	₹83 Cr	₹78 Cr	₹76 Cr	₹61 Cr	₹56 Cr	₹54 Cr	₹54 Cr	₹46 Cr
₹246 Cr	₹205 Cr	₹217 Cr	₹679 Cr	₹633 Cr	₹614 Cr	₹215 Cr	₹868 Cr	₹853 Cr	₹539 Cr	₹305 Cr	₹487 Cr	₹548 Cr	₹368 Cr	₹127 Cr	₹116 Cr	₹430 Cr	-₹5 Cr	₹132 Cr	₹109 Cr	₹127 Cr	₹105 Cr	₹113 Cr	₹302 Cr	₹190 Cr	₹151 Cr	₹160 Cr	₹168 Cr	₹212 Cr	₹179 Cr	₹232 Cr	₹261 Cr	₹254 Cr	₹403 Cr	₹298 Cr	₹127 Cr	₹140 Cr	₹241 Cr	₹266 Cr	₹108 Cr	₹82 Cr	₹94 Cr	₹67 Cr	₹60 Cr	₹59 Cr	₹53 Cr	₹55 Cr	₹62 Cr	₹59 Cr	₹47 Cr	₹55 Cr	₹45 Cr	₹48 Cr	₹36 Cr	₹51 Cr	₹44 Cr	₹32 Cr	₹27 Cr	₹32 Cr	₹32 Cr	₹27 Cr	₹23 Cr	₹25 Cr	₹28 Cr	₹21 Cr	₹24 Cr	₹24 Cr	₹25 Cr	₹19 Cr	₹23 Cr	₹21 Cr	₹20 Cr	₹19 Cr	₹20 Cr	₹19 Cr	₹17 Cr	₹13 Cr	₹14 Cr	₹15 Cr	₹14 Cr	₹13 Cr
₹13 Cr	₹11 Cr	₹10 Cr	₹13 Cr	₹3 Cr	₹10 Cr	₹4 Cr	₹4 Cr	₹5 Cr	₹6 Cr	₹5 Cr	₹4 Cr	₹4 Cr	₹3 Cr	₹4 Cr	₹4 Cr	₹4 Cr	₹7 Cr	₹5 Cr	₹4 Cr	₹2 Cr	₹4 Cr	₹3 Cr	₹3 Cr	₹4 Cr	₹4 Cr	₹5 Cr	₹6 Cr	₹7 Cr	₹5 Cr	₹6 Cr	₹5 Cr	₹3 Cr	₹3 Cr	₹4 Cr	₹4 Cr	₹4 Cr	₹6 Cr	₹5 Cr	₹4 Cr	₹3 Cr	₹4 Cr	₹4 Cr	₹8 Cr	₹8 Cr	₹9 Cr	₹9 Cr	₹7 Cr	₹7 Cr	₹7 Cr	₹9 Cr	₹10 Cr	₹10 Cr	₹8 Cr	₹8 Cr	₹6 Cr	₹4 Cr	₹6 Cr	₹6 Cr	₹6 Cr	₹5 Cr	₹4 Cr	₹4 Cr	₹4 Cr	₹4 Cr	₹4 Cr	₹4 Cr	₹4 Cr	₹4 Cr	₹4 Cr	₹5 Cr	₹4 Cr	₹3 Cr	₹2 Cr	₹3 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹4 Cr
₹186 Cr	₹144 Cr	₹161 Cr	₹614 Cr	₹572 Cr	₹506 Cr	₹164 Cr	₹818 Cr	₹804 Cr	₹478 Cr	₹256 Cr	₹440 Cr	₹500 Cr	₹324 Cr	₹81 Cr	₹70 Cr	₹386 Cr	-₹50 Cr	₹91 Cr	₹70 Cr	₹91 Cr	₹71 Cr	₹80 Cr	₹271 Cr	₹158 Cr	₹117 Cr	₹129 Cr	₹139 Cr	₹184 Cr	₹152 Cr	₹205 Cr	₹235 Cr	₹232 Cr	₹382 Cr	₹276 Cr	₹107 Cr	₹121 Cr	₹221 Cr	₹248 Cr	₹90 Cr	₹66 Cr	₹78 Cr	₹50 Cr	₹40 Cr	₹39 Cr	₹30 Cr	₹19 Cr	₹44 Cr	₹41 Cr	₹32 Cr	₹38 Cr	₹28 Cr	₹31 Cr	₹22 Cr	₹32 Cr	₹27 Cr	₹23 Cr	₹19 Cr	₹22 Cr	₹21 Cr	₹18 Cr	₹15 Cr	₹18 Cr	₹19 Cr	₹14 Cr	₹17 Cr	₹16 Cr	₹17 Cr	₹11 Cr	₹17 Cr	₹14 Cr	₹14 Cr	₹12 Cr	₹21 Cr	₹14 Cr	₹12 Cr	₹9 Cr	₹11 Cr	₹11 Cr	₹10 Cr	₹8 Cr
₹122 Cr	₹233 Cr	₹140 Cr	₹518 Cr	₹480 Cr	₹406 Cr	₹132 Cr	₹677 Cr	₹669 Cr	₹386 Cr	₹213 Cr	₹369 Cr	₹420 Cr	₹276 Cr	₹62 Cr	₹57 Cr	₹320 Cr	-₹51 Cr	₹80 Cr	₹65 Cr	₹75 Cr	₹53 Cr	₹63 Cr	₹204 Cr	₹122 Cr	₹93 Cr	₹104 Cr	₹118 Cr	₹143 Cr	₹120 Cr	₹159 Cr	₹182 Cr	₹181 Cr	₹300 Cr	₹217 Cr	₹84 Cr	₹94 Cr	₹176 Cr	₹195 Cr	₹66 Cr	₹48 Cr	₹60 Cr	₹37 Cr	₹29 Cr	₹28 Cr	₹53 Cr	₹14 Cr	₹31 Cr	₹32 Cr	₹25 Cr	₹27 Cr	₹24 Cr	₹21 Cr	₹10 Cr	₹21 Cr	₹20 Cr	₹18 Cr	₹13 Cr	₹17 Cr	₹16 Cr	₹14 Cr	₹14 Cr	₹13 Cr	₹15 Cr	₹11 Cr	₹14 Cr	₹12 Cr	₹13 Cr	₹8 Cr	₹11 Cr	₹12 Cr	₹12 Cr	₹9 Cr	₹12 Cr	₹12 Cr	₹11 Cr	₹7 Cr	₹9 Cr	₹10 Cr	₹8 Cr	₹4 Cr

Balance Sheet

Consolidated

Standalone

₹

Name

Equity And Liabilities

Share Capital

Share Warrants & Outstandings

Total Reserves

Reserve excluding Revaluation Reserve

Shareholder's Funds

Minority Interest

Secured Loans

Unsecured Loans

Deferred Tax Assets / Liabilities

Other Long Term Liabilities

Long Term Provisions

Total Non-Current Liabilities

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Current Liabilities

Total Liabilities

Contingent Liabilities

Total Debt

Assets

Gross Block

Less Accumulated Depreciation

Less Impairment of Assets

Net Block

Capital Work in Progress

Non Current Investments

Long Term Investment

Long Term Loans & Advances

Other Non Current Assets

Total Non-Current Assets

Current Assets Loans & Advances

Currents Investments

Inventories

Sundry Debtors

Cash and Bank

Other Current Assets

Short Term Loans and Advances

Total Current Assets

Net Current Assets (Including Current Investments)

Miscellaneous Expenses not written off

Total Assets

Book Value

Adjusted Book Value

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011	Mar 2010	Mar 2009	Mar 2008	Mar 2007	Mar 2006	Mar 2005
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹36 Cr	₹36 Cr	₹36 Cr	₹37 Cr	₹37 Cr	₹37 Cr	₹36 Cr	₹37 Cr	₹37 Cr	₹35 Cr	₹35 Cr	₹33 Cr	₹33 Cr	₹31 Cr	₹31 Cr	₹28 Cr	₹28 Cr	₹28 Cr	₹28 Cr	₹28 Cr	₹27 Cr	₹26 Cr
₹0	₹0	₹0	₹0	₹3 Cr	₹18 Cr	₹24 Cr	₹31 Cr	₹24 Cr	₹15 Cr	₹10 Cr	₹0	₹0	₹0	₹0	₹0	₹0	₹1 Cr	₹7 Cr	₹7 Cr	₹5 Cr	₹1 Cr
₹9185 Cr	₹7571 Cr	₹5817 Cr	₹4837 Cr	₹4224 Cr	₹4068 Cr	₹3714 Cr	₹3422 Cr	₹3011 Cr	₹1599 Cr	₹1251 Cr	₹813 Cr	₹693 Cr	₹502 Cr	₹442 Cr	₹324 Cr	₹278 Cr	₹230 Cr	₹183 Cr	₹146 Cr	₹115 Cr	₹86 Cr
₹9185 Cr	₹7571 Cr	₹5817 Cr	₹4837 Cr	₹4224 Cr	₹4068 Cr	₹3714 Cr	₹3422 Cr	₹3011 Cr	₹1599 Cr	₹1251 Cr	₹813 Cr	₹693 Cr	₹502 Cr	₹442 Cr	₹324 Cr	₹278 Cr	₹230 Cr	₹183 Cr	₹146 Cr	₹115 Cr	₹86 Cr
₹9221 Cr	₹7607 Cr	₹5853 Cr	₹4874 Cr	₹4264 Cr	₹4122 Cr	₹3774 Cr	₹3489 Cr	₹3072 Cr	₹1649 Cr	₹1296 Cr	₹846 Cr	₹726 Cr	₹534 Cr	₹474 Cr	₹352 Cr	₹306 Cr	₹259 Cr	₹218 Cr	₹180 Cr	₹148 Cr	₹114 Cr
₹0	₹5 Cr	₹0	₹0	₹0	₹2 Cr	₹11 Cr	₹2 Cr	₹4 Cr	₹4 Cr	₹5 Cr	₹5 Cr	₹7 Cr	₹11 Cr	₹88 L	₹1 Cr	₹5 Cr	₹7 Cr	₹7 Cr	₹6 Cr	₹6 Cr	₹0
₹100 Cr	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹94 Cr	₹92 Cr	₹136 Cr	₹134 Cr	₹125 Cr	₹114 Cr	₹121 Cr	₹89 Cr	₹65 Cr	₹63 Cr	₹85 Cr
₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹3 Cr	₹3 Cr	₹2 Cr	₹22 L	₹22 L	₹5 Cr	₹6 Cr	₹6 Cr	₹12 Cr	₹17 Cr	₹26 Cr
-₹232 Cr	-₹50 Cr	-₹19 Cr	₹12 Cr	₹30 Cr	₹41 Cr	₹26 Cr	₹12 Cr	₹14 Cr	₹15 Cr	₹15 Cr	₹12 Cr	₹43 Cr	₹44 Cr	₹29 Cr	₹25 Cr	₹27 Cr	₹24 Cr	₹20 Cr	₹18 Cr	₹15 Cr	₹16 Cr
₹10 Cr	₹9 Cr	₹9 Cr	₹3 Cr	₹9 Cr	₹2 Cr	₹2 Cr	₹80 L	₹80 L	₹80 L	₹80 L	₹83 L	₹1 Cr	₹69 L	₹1 Cr	₹1 Cr	₹0	₹0	₹0	₹0	₹0	₹0
₹62 Cr	₹66 Cr	₹71 Cr	₹85 Cr	₹96 Cr	₹100 Cr	₹90 Cr	₹71 Cr	₹32 Cr	₹22 Cr	₹13 Cr	₹9 Cr	₹11 Cr	₹9 Cr	₹7 Cr	₹9 Cr	₹0	₹0	₹0	₹0	₹0	₹0
-₹61 Cr	₹25 Cr	₹61 Cr	₹101 Cr	₹135 Cr	₹143 Cr	₹118 Cr	₹83 Cr	₹47 Cr	₹38 Cr	₹28 Cr	₹119 Cr	₹151 Cr	₹191 Cr	₹171 Cr	₹160 Cr	₹146 Cr	₹150 Cr	₹115 Cr	₹94 Cr	₹95 Cr	₹127 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹409 Cr	₹275 Cr	₹236 Cr	₹264 Cr	₹162 Cr	₹146 Cr	₹255 Cr	₹217 Cr	₹269 Cr	₹263 Cr	₹276 Cr	₹125 Cr	₹110 Cr	₹106 Cr	₹92 Cr	₹77 Cr	₹83 Cr	₹87 Cr	₹72 Cr	₹60 Cr	₹56 Cr	₹34 Cr
₹615 Cr	₹239 Cr	₹239 Cr	₹227 Cr	₹127 Cr	₹100 Cr	₹97 Cr	₹110 Cr	₹133 Cr	₹127 Cr	₹114 Cr	₹119 Cr	₹102 Cr	₹90 Cr	₹82 Cr	₹44 Cr	₹9 Cr	₹12 Cr	₹2 Cr	₹6 Cr	₹3 Cr	₹13 Cr
₹306 Cr	₹273 Cr	₹363 Cr	₹165 Cr	₹404 Cr	₹266 Cr	₹314 Cr	₹386 Cr	₹173 Cr	₹222 Cr	₹98 Cr	₹169 Cr	₹99 Cr	₹148 Cr	₹82 Cr	₹72 Cr	₹0	₹0	₹0	₹0	₹0	₹0
₹351 Cr	₹157 Cr	₹135 Cr	₹27 Cr	₹18 Cr	₹14 Cr	₹19 Cr	₹16 Cr	₹16 Cr	₹15 Cr	₹5 Cr	₹1 Cr	₹2 Cr	₹1 Cr	₹3 Cr	₹91 L	₹6 Cr	₹11 Cr	₹5 Cr	₹4 Cr	₹0	₹0
₹1681 Cr	₹944 Cr	₹973 Cr	₹683 Cr	₹710 Cr	₹526 Cr	₹685 Cr	₹729 Cr	₹592 Cr	₹627 Cr	₹493 Cr	₹414 Cr	₹312 Cr	₹345 Cr	₹259 Cr	₹193 Cr	₹97 Cr	₹110 Cr	₹80 Cr	₹69 Cr	₹59 Cr	₹47 Cr
₹10841 Cr	₹8581 Cr	₹6887 Cr	₹5657 Cr	₹5109 Cr	₹4792 Cr	₹4588 Cr	₹4303 Cr	₹3715 Cr	₹2318 Cr	₹1822 Cr	₹1384 Cr	₹1196 Cr	₹1080 Cr	₹905 Cr	₹707 Cr	₹554 Cr	₹526 Cr	₹419 Cr	₹350 Cr	₹308 Cr	₹287 Cr
₹3 Cr	₹3 Cr	₹40 L	₹15 Cr	₹8 Cr	₹1 Cr	₹1 Cr	₹3 Cr	₹1 Cr	₹1 Cr	₹2 Cr	₹1 Cr	₹24 Cr	₹24 Cr	₹57 Cr	₹71 Cr	₹21 Cr	₹35 Cr	₹54 Cr	₹24 Cr	₹19 Cr	₹21 Cr
₹706 Cr	₹273 Cr	₹363 Cr	₹165 Cr	₹404 Cr	₹266 Cr	₹314 Cr	₹386 Cr	₹173 Cr	₹222 Cr	₹113 Cr	₹312 Cr	₹240 Cr	₹338 Cr	₹259 Cr	₹220 Cr	₹120 Cr	₹126 Cr	₹94 Cr	₹76 Cr	₹80 Cr	₹111 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹4256 Cr	₹4015 Cr	₹3603 Cr	₹3375 Cr	₹3127 Cr	₹2702 Cr	₹2149 Cr	₹1695 Cr	₹1408 Cr	₹1159 Cr	₹983 Cr	₹940 Cr	₹820 Cr	₹727 Cr	₹440 Cr	₹374 Cr	₹357 Cr	₹311 Cr	₹273 Cr	₹208 Cr	₹182 Cr	₹135 Cr
₹1403 Cr	₹1267 Cr	₹1112 Cr	₹948 Cr	₹815 Cr	₹679 Cr	₹564 Cr	₹467 Cr	₹389 Cr	₹326 Cr	₹273 Cr	₹226 Cr	₹171 Cr	₹141 Cr	₹117 Cr	₹104 Cr	₹95 Cr	₹76 Cr	₹62 Cr	₹53 Cr	₹46 Cr	₹39 Cr
₹50 Cr	₹50 Cr	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹4 Cr	₹4 Cr	₹4 Cr	₹3 Cr	₹0	₹0	₹0	₹0	₹0	₹0	₹0
₹2803 Cr	₹2698 Cr	₹2491 Cr	₹2427 Cr	₹2312 Cr	₹2023 Cr	₹1584 Cr	₹1227 Cr	₹1019 Cr	₹833 Cr	₹710 Cr	₹710 Cr	₹645 Cr	₹583 Cr	₹320 Cr	₹270 Cr	₹262 Cr	₹234 Cr	₹210 Cr	₹155 Cr	₹136 Cr	₹96 Cr
₹294 Cr	₹225 Cr	₹137 Cr	₹64 Cr	₹130 Cr	₹223 Cr	₹518 Cr	₹638 Cr	₹480 Cr	₹336 Cr	₹212 Cr	₹129 Cr	₹124 Cr	₹106 Cr	₹164 Cr	₹76 Cr	₹40 Cr	₹47 Cr	₹18 Cr	₹20 Cr	₹11 Cr	₹9 Cr
₹2549 Cr	₹153 Cr	₹96 Cr	₹87 Cr	₹104 Cr	₹152 Cr	₹84 Cr	₹20 Cr	₹8 Cr	₹10 L	₹10 L	₹2 Cr	₹2 Cr	₹2 Cr	₹62 Cr	₹62 Cr	₹60 Cr	₹34 Cr	₹5 L	₹2 Cr	₹6 L	₹4 L
₹2549 Cr	₹153 Cr	₹96 Cr	₹87 Cr	₹104 Cr	₹152 Cr	₹84 Cr	₹20 Cr	₹8 Cr	₹10 L	₹10 L	₹2 Cr	₹2 Cr	₹2 Cr	₹62 Cr	₹62 Cr	₹60 Cr	₹34 Cr	₹5 L	₹2 Cr	₹6 L	₹4 L
₹101 Cr	₹74 Cr	₹113 Cr	₹78 Cr	₹72 Cr	₹44 Cr	₹72 Cr	₹63 Cr	₹70 Cr	₹55 Cr	₹59 Cr	₹57 Cr	₹54 Cr	₹57 Cr	₹66 Cr	₹51 Cr	₹0	₹0	₹0	₹0	₹0	₹0
₹43 Cr	₹161 Cr	₹27 Cr	₹30 L	₹5 Cr	₹4 Cr	₹4 Cr	₹8 Cr	₹8 Cr	₹6 Cr	₹4 Cr	₹4 Cr	₹3 Cr	₹3 Cr	₹42 L	₹96 L	₹0	₹0	₹0	₹0	₹0	₹0
₹5789 Cr	₹3311 Cr	₹2863 Cr	₹2657 Cr	₹2622 Cr	₹2447 Cr	₹2262 Cr	₹1956 Cr	₹1584 Cr	₹1230 Cr	₹985 Cr	₹901 Cr	₹828 Cr	₹750 Cr	₹612 Cr	₹460 Cr	₹362 Cr	₹316 Cr	₹229 Cr	₹177 Cr	₹147 Cr	₹105 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹578 Cr	₹321 Cr	₹444 Cr	₹305 Cr	₹204 Cr	₹152 Cr	₹29 Cr	₹149 Cr	₹68 Cr	₹32 Cr	₹22 Cr	₹12 L	₹32 L	₹81 L	₹74 L	₹82 L	₹31 L	₹0	₹0	₹0	₹0	₹15 Cr
₹909 Cr	₹766 Cr	₹701 Cr	₹743 Cr	₹762 Cr	₹798 Cr	₹558 Cr	₹529 Cr	₹438 Cr	₹349 Cr	₹357 Cr	₹220 Cr	₹181 Cr	₹146 Cr	₹110 Cr	₹102 Cr	₹77 Cr	₹80 Cr	₹68 Cr	₹52 Cr	₹46 Cr	₹38 Cr
₹881 Cr	₹1247 Cr	₹1189 Cr	₹856 Cr	₹621 Cr	₹413 Cr	₹551 Cr	₹506 Cr	₹638 Cr	₹475 Cr	₹262 Cr	₹192 Cr	₹119 Cr	₹130 Cr	₹95 Cr	₹71 Cr	₹57 Cr	₹62 Cr	₹38 Cr	₹34 Cr	₹38 Cr	₹33 Cr
₹1551 Cr	₹2176 Cr	₹953 Cr	₹546 Cr	₹206 Cr	₹284 Cr	₹66 Cr	₹280 Cr	₹184 Cr	₹36 Cr	₹45 Cr	₹13 Cr	₹11 Cr	₹11 Cr	₹37 Cr	₹32 Cr	₹8 Cr	₹29 Cr	₹26 Cr	₹29 Cr	₹31 Cr	₹46 Cr
₹102 Cr	₹135 Cr	₹100 Cr	₹64 Cr	₹88 Cr	₹95 Cr	₹92 Cr	₹107 Cr	₹53 Cr	₹26 Cr	₹25 Cr	₹6 Cr	₹4 Cr	₹4 Cr	₹9 Cr	₹4 Cr	₹3 Cr	₹77 L	₹8 Cr	₹8 Cr	₹7 Cr	₹4 Cr
₹1031 Cr	₹626 Cr	₹638 Cr	₹486 Cr	₹606 Cr	₹604 Cr	₹1030 Cr	₹776 Cr	₹750 Cr	₹170 Cr	₹125 Cr	₹51 Cr	₹52 Cr	₹39 Cr	₹42 Cr	₹37 Cr	₹46 Cr	₹39 Cr	₹50 Cr	₹51 Cr	₹36 Cr	₹40 Cr
₹5052 Cr	₹5270 Cr	₹4024 Cr	₹3000 Cr	₹2487 Cr	₹2345 Cr	₹2326 Cr	₹2347 Cr	₹2131 Cr	₹1087 Cr	₹837 Cr	₹483 Cr	₹368 Cr	₹330 Cr	₹293 Cr	₹247 Cr	₹193 Cr	₹211 Cr	₹190 Cr	₹172 Cr	₹158 Cr	₹176 Cr
₹3371 Cr	₹4327 Cr	₹3051 Cr	₹2317 Cr	₹1776 Cr	₹1819 Cr	₹1640 Cr	₹1619 Cr	₹1539 Cr	₹461 Cr	₹344 Cr	₹69 Cr	₹56 Cr	-₹14 Cr	₹33 Cr	₹54 Cr	₹95 Cr	₹101 Cr	₹111 Cr	₹103 Cr	₹98 Cr	₹129 Cr
₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹29 L	₹62 L	₹3 Cr	₹6 Cr
₹10841 Cr	₹8581 Cr	₹6887 Cr	₹5657 Cr	₹5109 Cr	₹4792 Cr	₹4588 Cr	₹4303 Cr	₹3715 Cr	₹2318 Cr	₹1822 Cr	₹1384 Cr	₹1196 Cr	₹1080 Cr	₹905 Cr	₹707 Cr	₹554 Cr	₹526 Cr	₹419 Cr	₹350 Cr	₹308 Cr	₹287 Cr
₹515	₹425	₹327	₹267	₹233	₹225	₹206	₹189	₹165	₹94	₹74	₹255	₹219	₹170	₹152	₹125	₹109	₹92	₹75	₹63	₹51	₹41
₹515	₹425	₹327	₹267	₹233	₹225	₹206	₹189	₹165	₹94	₹74	₹51	₹44	₹34	₹30	₹25	₹22	₹18	₹15	₹13	₹10	₹8

Cash Flow

Consolidated

Standalone

₹

Name

Profit Before Tax

Adjustment

Changes In working Capital

Cash Flow after changes in Working Capital

Cash Flow from Operating Activities

Cash Flow from Investing Activities

Cash Flow from Financing Activitie

Net Cash Inflow / Outflow

Opening Cash & Cash Equivalents

Effect of Foreign Exchange Fluctuations

Closing Cash & Cash Equivalent

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011	Mar 2010	Mar 2009	Mar 2008	Mar 2007
₹1491 Cr	₹2291 Cr	₹1674 Cr	₹862 Cr	₹202 Cr	₹580 Cr	₹569 Cr	₹825 Cr	₹887 Cr	₹624 Cr	₹209 Cr	₹134 Cr	₹129 Cr	₹102 Cr	₹80 Cr	₹65 Cr	₹62 Cr	₹57 Cr	₹55 Cr	₹40 Cr
₹30 Cr	-₹22 Cr	₹134 Cr	₹102 Cr	₹124 Cr	₹62 Cr	₹54 Cr	₹14 Cr	₹76 Cr	₹100 Cr	₹91 Cr	₹68 Cr	₹66 Cr	₹49 Cr	₹37 Cr	₹39 Cr	₹44 Cr	₹30 Cr	₹9 Cr	₹16 Cr
₹646 Cr	-₹200 Cr	-₹309 Cr	₹63 Cr	-₹231 Cr	-₹213 Cr	-₹98 Cr	₹9 Cr	-₹295 Cr	-₹253 Cr	-₹141 Cr	-₹86 Cr	-₹16 Cr	-₹67 Cr	-₹28 Cr	-₹49 Cr	-₹11 Cr	-₹16 Cr	-₹4 Cr	-₹7 Cr
₹2166 Cr	₹2069 Cr	₹1498 Cr	₹1027 Cr	₹95 Cr	₹429 Cr	₹525 Cr	₹848 Cr	₹668 Cr	₹472 Cr	₹158 Cr	₹116 Cr	₹179 Cr	₹84 Cr	₹89 Cr	₹55 Cr	₹95 Cr	₹71 Cr	₹60 Cr	₹48 Cr
₹1768 Cr	₹1697 Cr	₹1212 Cr	₹849 Cr	₹47 Cr	₹299 Cr	₹417 Cr	₹669 Cr	₹464 Cr	₹346 Cr	₹112 Cr	₹93 Cr	₹144 Cr	₹61 Cr	₹65 Cr	₹37 Cr	₹77 Cr	₹61 Cr	₹48 Cr	₹45 Cr
-₹2082 Cr	-₹1415 Cr	-₹1033 Cr	-₹477 Cr	-₹5 Cr	-₹103 Cr	-₹167 Cr	-₹612 Cr	-₹1116 Cr	-₹299 Cr	-₹176 Cr	-₹115 Cr	-₹109 Cr	-₹107 Cr	-₹127 Cr	-₹89 Cr	-₹61 Cr	-₹74 Cr	-₹60 Cr	-₹39 Cr
₹298 Cr	-₹211 Cr	-₹247 Cr	-₹363 Cr	₹35 Cr	-₹186 Cr	-₹251 Cr	-₹51 Cr	₹651 Cr	-₹48 Cr	₹154 Cr	₹29 Cr	-₹35 Cr	₹26 Cr	₹63 Cr	₹77 Cr	-₹34 Cr	₹16 Cr	₹9 Cr	-₹8 Cr
-₹16 Cr	₹72 Cr	-₹68 Cr	₹9 Cr	₹76 Cr	₹10 Cr	-₹50 L	₹6 Cr	-₹1 Cr	-₹1 Cr	₹91 Cr	₹7 Cr	-₹15 L	-₹20 Cr	₹78 L	₹25 Cr	-₹18 Cr	₹3 Cr	-₹3 Cr	-₹2 Cr
₹120 Cr	₹70 Cr	₹132 Cr	₹111 Cr	₹26 Cr	₹20 Cr	₹28 Cr	₹22 Cr	₹24 Cr	₹24 Cr	-₹164 Cr	₹10 Cr	₹10 Cr	₹35 Cr	₹32 Cr	₹7 Cr	₹27 Cr	₹24 Cr	₹29 Cr	₹31 Cr
₹95 Cr	-₹22 Cr	₹7 Cr	₹12 Cr	₹9 Cr	-₹4 Cr	-₹8 Cr	₹90 L	-₹80 L	₹60 L	-₹80 L	-₹5 Cr	₹42 L	-₹5 Cr	₹2 Cr	-₹14 L	-₹3 Cr	₹74 L	₹0	₹0
₹199 Cr	₹120 Cr	₹70 Cr	₹132 Cr	₹111 Cr	₹26 Cr	₹20 Cr	₹28 Cr	₹22 Cr	₹24 Cr	-₹74 Cr	₹12 Cr	₹10 Cr	₹10 Cr	₹35 Cr	₹32 Cr	₹7 Cr	₹27 Cr	₹26 Cr	₹29 Cr

Fundamental Ratios

Consolidated

Standalone

No results found

Natco Pharma Share Price

781.60+0.00 (-0.53%)

-5.23% past 1 Year

Technical meters

Oscillators

Strong SellSellNeutralBuyStrong Buy

Bullish signals: 0

Bearish signals: 6 out of 9 oscillators

RSI

38.76Sell

STOCH %K

22.10Neutral

MACD Level(12,26)

-9.85Sell

Ultimate Oscillator

41.51Sell

Aroon Oscillator

-82.00Sell

BOP

-0.85Sell

CCI

-73.70Neutral

Williams %R

-77.90Neutral

Momentum

-7.55Sell

Moving averages

Strong SellSellNeutralBuyStrong Buy

Bullish signals: 0

Bearish signals: 9 out of 9 moving averages

EMA 9

787.38Sell

SMA 9

788.01Sell

EMA 21

794.99Sell

SMA 21

793.32Sell

EMA 50

820.43Sell

SMA 50

814.73Sell

EMA 200

887.66Sell

SMA 200

921.25Sell

WMA 20

788.59Sell

Pivot

Classic

Resistance 5

829.35

Resistance 4

818.55

Resistance 3

807.75

Resistance 2

796.95

Resistance 1

791.35

Pivot

786.15

Support 1

780.55

Support 2

775.35

Support 3

764.55

Support 4

753.75

Support 5

742.95

High & lows

1 Day

1 Week

1 Month

3 Months

6 Months

Year to Date

1 Year

3 Years

5 Years

10 Years

All Time

Low

779.20

773.60

720.88

497.91

399.27

1.60

High

794.90

827.00

956.99

1216.81

1625.65

Returns

+0.00

-0.80

-39.90

-123.47

-383.53

-114.10

-43.13

+44.06

-71.00

+209.15

+776.54

Beta

—

Std. deviation %

—

Open a free Demat account in minutes to start investing and screening .

Natco Pharma Share Price

781.60+0.00 (-0.53%)

-5.23% past 1 Year

Shareholding summary

Promoters

49.39%

FII

15.99%

DII

3.9%

2.25%

Others

28.47%

Promoters

FII

DII

Others

Quarterly

Yearly

Shareholding Pattern

Quarterly

Yearly

Name

Promoters

FII

DII - Others

DII - MFs

Retail & Others

Sep 2026	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025
49.39%	49.42%	49.42%	49.48%	49.48%	49.56%
15.99%	16.99%	17.37%	15.16%	14.09%	15.52%
3.90%	3.70%	3.73%	3.78%	3.67%	3.53%
2.25%	1.92%	1.72%	1.60%	2.20%	2.11%
28.47%	27.97%	27.76%	29.98%	30.56%	29.28%

Bulk & block deals

Name

Graviton Research Capital Llp

The Jupiter Global Fund-Jupiter India Select

Jupiter South Asia Investment Company Limited

Societe Generale

Bnp Paribas Arbitrage

Deal Date	Action	Deal Value	Deal Price	Qty Traded	Deal Type	%Stake Traded	Exchange
26 Nov 2025	Purchase	108.42 Cr	₹904.19	11.99 L	Bulk	0.669446	NSE
26 Nov 2025	Sell	108.54 Cr	₹904.93	11.99 L	Bulk	0.669651	NSE
24 Apr 2025	Purchase	165.95 Cr	₹929.71	17.85 L	Bulk	0.996548	NSE
24 Apr 2025	Sell	166.03 Cr	₹930.19	17.85 L	Bulk	0.996548	NSE
14 Feb 2025	Purchase	86.57 Cr	₹890.86	9.72 L	Bulk	0.542531	NSE
14 Feb 2025	Sell	86.58 Cr	₹891.03	9.72 L	Bulk	0.542531	NSE
21 Feb 2024	Purchase	20.65 Cr	₹1,039.15	1.99 L	Block	0.110961	BSE
21 Feb 2024	Sell	20.65 Cr	₹1,039.15	1.99 L	Block	0.110961	BSE
25 Jan 2024	Purchase	56.94 Cr	₹859.20	6.63 L	Block	0.370015	BSE
25 Jan 2024	Sell	12.88 Cr	₹859.20	1.50 L	Block	0.083706	BSE

Insider trading & SAST

Client name

Kantamani Ratna Kumar

Neerukonda Srinivas

Time Cap Phama Labs Pvt Ltd

Sandeep Kumar

Rajeev Nannapaneni

Nitin Jain (Huf)

Sivaramakrishna Prasad Potluri

Lingarao Donthineni

G Vasan

Lakshmi Narayana Are

Reported on	Client category	Action	%Stake traded	Holding % post deal	Deal value	Deal price	Qty traded	Deal period	Deal mode	Post transaction holding	Insider/SAST	Regulation type	Security type
29 Oct 2026	Promoter Group	Acquisition	0.002427	0.03	35.71 L	₹750	4.76 K	26 Oct 2026	Allotment	54,761	Insider Trading	—	Equity
29 Oct 2026	Designated Person	Acquisition	0.000122	0	1.80 L	₹750	240	26 Oct 2026	Allotment	1,290	Insider Trading	—	Equity
29 Oct 2026	Promoter Group	Acquisition	0.475782	9.23	70 Cr	₹750	9.33 L	26 Oct 2026	Allotment	1,81,08,753	Insider Trading	—	Equity
29 Oct 2026	Designated Person	Acquisition	0.000011	0	16.50 K	₹750	22	26 Oct 2026	Allotment	140	Insider Trading	—	Equity
29 Oct 2026	Promoter and Director	Acquisition	0.029906	0.58	4.40 Cr	₹750	58.67 K	26 Oct 2026	Allotment	11,36,666	Insider Trading	—	Equity
29 Oct 2026	Director	Acquisition	0.001529	0	22.50 L	₹750	3 K	26 Oct 2026	Allotment	3,000	Insider Trading	—	Equity
29 Oct 2026	Director	Acquisition	0.002039	0.2	30 L	₹750	4 K	26 Oct 2026	Allotment	45,150	Insider Trading	—	Equity
29 Oct 2026	Director	Acquisition	0.002629	0.3	38.68 L	₹750	5.16 K	26 Oct 2026	Allotment	59,312	Insider Trading	—	Equity
29 Oct 2026	Designated Person	Acquisition	0.000153	0	2.25 L	₹750	300	26 Oct 2026	Allotment	1,000	Insider Trading	—	Equity
29 Oct 2026	Designated Person	Acquisition	0.002294	0.03	33.75 L	₹750	4.50 K	26 Oct 2026	Allotment	15,613	Insider Trading	—	Equity

Natco Pharma Share Price

781.60+0.00 (-0.53%)

-5.23% past 1 Year

Corporate Actions

Date

Type

Details

2026-10-01

Rights

2:21;750.0 (Rights ratio;Offer price)

2026-09-09

Demerger

2026-08-20

Dividend

1.5

2026-02-18

Dividend

1.5

2025-11-20

Dividend

1.5

2025-11-14

Demerger

2025-08-19

Dividend

2.0

2025-02-18

Dividend

1.5

2024-11-27

Dividend

1.5

2024-08-23

Dividend

3.0

2024-02-26

Dividend

1.25

2023-11-24

Dividend

1.25

2023-08-22

Dividend

7.0

2023-02-21

Dividend

1.25

2022-11-21

Dividend

0.75

2022-08-19

Dividend

3.5

2022-02-24

Dividend

2.0

2021-08-24

Dividend

2.0

2021-02-22

Dividend

1.0

2020-11-24

Dividend

3.0

2020-08-21

Dividend

1.25

2020-06-26

Dividend

1.0

2020-02-24

Dividend

3.5

2019-11-21

Dividend

1.0

2019-08-22

Dividend

1.25

2019-06-06

Dividend

1.25

2019-02-21

Dividend

3.5

2018-08-20

Dividend

1.5

2018-02-15

Dividend

7.0

2017-08-16

Dividend

1.25

2017-02-23

Dividend

6.0

2016-08-19

Dividend

0.75

2016-02-22

Dividend

1.25

2015-11-26

Split

10:2

2015-02-24

Dividend

5.0

2014-02-24

Dividend

5.0

2013-02-22

Dividend

4.0

2012-02-22

Dividend

3.0

2011-02-24

Dividend

2.0

Company details

Registered office

Natco House Road No 2 Banjara Hills Hyderabad Telangana PIN: 500034 Tel No: 040-23547532 Fax No: 040-23548243 Email: [email protected] / [email protected] Internet: www.natcopharma.co.in

Registrars

Aurum, Door No 4-50/P-II/57/4F&5F Plot No 57, 4th & 5th Floors, Jayabheri Enclave Phase - II, Gachibowli(Old Address:12-10-167, MIG- 167,Bharat Nagar Colony, Hyderabad – 500018.)Phone: +91-40-23818475/6Fax : +91-40-23868024Email: info@vccili Aurum, Door No 4-50/P-II/57/4F&5F Plot No 57 4th & 5th Floors Jayabheri Enclave Phase - II, Gachibowli PIN: Tel No: 23818475,23868257,35164910 Fax No: NULL Email: [email protected] Internet: www.vccipl.com

Management

Chekuri Venkat Ramesh, Company Secretary & Compliance Officer

V C Nannapaneni, Chairman & Managing Director

Rajeev Nannapaneni, Vice Chairman & CEO

ADM Chavali, Non Executive Independent Director

Lakshminarayana Bolisetty, Non Executive Independent Director

Kantipudi Suma, Non Executive Independent Director

Nitin Jain, Non Executive Independent Director

Dronadula Vijaya Bhaskar, Non Executive Independent Director

D Linga Rao, Whole Time Director - Technical

PSRK Prasad, Whole Time Director - Corporate Engineering Services

Details

BSE 524816

NSE NATCOPHARM

ISIN INE987B01026

Natco Pharma Share Price

Price Analysis

Share Price Live Stats

Share Market Cap & Key Ratios Overview

About

Stock Analysis (SWOT)

QVT

Peer Stocks

Natco Pharma Share Price

Natco Pharma Share Price

Financial overview

Compounded Sales Growth

Compounded Profit Growth

Stock Price CAGR

Return on Equity

Peer Comparison

Profit & Loss

Balance Sheet

Cash Flow

Fundamental Ratios

Natco Pharma Share Price

Natco Pharma Share Price

Oscillators

Moving averages

Natco Pharma Share Price

Shareholding summary

Shareholding Pattern

Bulk & block deals

Insider trading & SAST

Natco Pharma Share Price

Corporate Actions

Company details

Natco Pharma Share Price

Corporate filings & documents

Announcements

Annual reports

Concalls & investor presentations

Natco Pharma Share Price

News

Natco Pharma launches generic Carboplatin Injection in United States

Natco Pharma Approves Rs 1,279.36 Crore Rights Issue At Rs 750

Natco Pharma suggests new rights issue with draft offer letter attached

Natco Pharma board approves fund raise of up to Rs 1,300 crores

Natco Pharma board to evaluate equity and securities-based fund raise options

Natco Pharma to host analyst and investor meet on September 7 morning

Natco Pharma increases strategic investment in US-based biotech Egenesis Inc

Natco Pharma schedules analyst and investor meeting on August 27, 2026

Natco Pharma receives USFDA Form 483 with four observations at Visakhapatnam

Natco Pharma schedules analyst and investor meetings on August 24 and 26

Natco Pharma targets double-digit domestic growth and agri export expansion

Natco Pharma declares interim dividend of Rs 1.50 per share

Natco Pharma approves fund raising plan of Rs 2,000 crore

Natco Pharma Q1 revenue falls sharply year on year

Natco Pharma reports lower Q1 EBITDA and margin decline year on year

Natco Pharma Q1 net profit falls to Rs 210 crores year on year

Natco Pharma gets tentative USFDA nod for Olaparib tablets, US deal

Natco Pharma boosts Adcock Ingram stake with additional 13.25 percent acquisition

Natco Pharma to boost profit after raising Adcock Ingram stake to 49 percent

Natco Pharma to raise Adcock Ingram stake to 49 percent via Rs 1,069 crore deal

Natco Pharma Ltd Share Price Today

Natco Pharma Quick Links

Other Stocks

Calculators

Brokerage Calculator

Stock Average Calculator

MTF Calculator

Margin Calculator

Span Margin Calculator